On Tuesday, Pfizer Inc. (NYSE: PFE) was -0.31% drop from the session before settling in for the closing price of $28.93. A 52-week range for PFE has been $25.20 – $31.54.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Healthcare Sector giant saw their annual sales surged by 10.96% over the last five years. When this article was written, the company’s average yearly earnings per share was at 44.63%. With a float of $5.66 billion, this company’s outstanding shares have now reached $5.67 billion.
The firm has a total of 88000 workers. Let’s measure their productivity. In terms of profitability, gross margin is 48.57%, operating margin of 2.84%, and the pretax margin is -7.48%.
Pfizer Inc. (PFE) Breakdown of a Key Holders of the stock
Also, it is sometimes useful to examine the sentiment of large-scale investors toward Pfizer Inc. stocks. The insider ownership of Pfizer Inc. is 0.03%, while institutional ownership is 67.41%. The most recent insider transaction that took place on Aug 13 ’24, was worth 147,714. In this transaction SVP & Controller of this company sold 5,154 shares at a rate of $28.66, taking the stock ownership to the 8,582 shares. Before that another transaction happened on Dec 15 ’23, when Company’s Director bought 3,000 for $26.47, making the entire transaction worth $79,401. This insider now owns 9,000 shares in total.
Pfizer Inc. (PFE) Recent Fiscal highlights
Going through the last 3-months fiscal report unveiled on the 6/30/2024, it has been observed that the corporation posted -0.17 earnings per share (EPS) during the time that was better than consensus figure (set at -0.34) by 0.17. Wall Street market experts anticipate that the next fiscal year will bring earnings of 0.66 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 44.63% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 8.00% during the next five years compared to -27.43% drop over the previous five years of trading.
Pfizer Inc. (NYSE: PFE) Trading Performance Indicators
You can see what Pfizer Inc. (PFE) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 0.60. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 2.94. Likewise, its price to free cash flow for the trailing twelve months is 33.98.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.46, a number that is poised to hit 0.62 in the next quarter and is forecasted to reach 2.87 in one year’s time.
Technical Analysis of Pfizer Inc. (PFE)
Analysing the last 5-days average volume posted by the [Pfizer Inc., PFE], we can find that recorded value of 25.77 million was lower than the volume posted last year of 37.0 million. As of the previous 9 days, the stock’s Stochastic %D was 14.90%. Additionally, its Average True Range was 0.54.
During the past 100 days, Pfizer Inc.’s (PFE) raw stochastic average was set at 42.18%, which indicates a significant increase from 27.40% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 23.79% in the past 14 days, which was higher than the 20.60% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $29.07, while its 200-day Moving Average is $28.21. Now, the first resistance to watch is $29.02. This is followed by the second major resistance level at $29.19. The third major resistance level sits at $29.40. If the price goes on to break the first support level at $28.63, it is likely to go to the next support level at $28.42. Now, if the price goes above the second support level, the third support stands at $28.25.
Pfizer Inc. (NYSE: PFE) Key Stats
There are 5,666,593K outstanding shares of the company, which has a market capitalization of 163.43 billion. As of now, sales total 58,496 M while income totals 2,119 M. Its latest quarter income was 13,283 M while its last quarter net income were 41,000 K.
